Astrana Health (NASDAQ:ASTH) Price Target Cut to $56.00 by Analysts at Stifel Nicolaus

Astrana Health (NASDAQ:ASTH - Free Report) had its price objective reduced by Stifel Nicolaus from $70.00 to $56.00 in a report released on Thursday,Benzinga reports. They currently have a buy rating on the stock.

A number of other brokerages have also commented on ASTH. Truist Financial dropped their price objective on shares of Astrana Health from $59.00 to $50.00 and set a "buy" rating on the stock in a report on Monday, January 13th. Robert W. Baird raised their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. Finally, Macquarie upgraded shares of Astrana Health to a "hold" rating in a report on Monday, December 16th. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $63.00.

Astrana Health Trading Down 4.6 %

ASTH traded down $1.71 during mid-day trading on Thursday, hitting $35.68. The stock had a trading volume of 291,742 shares, compared to its average volume of 249,265. The stock's fifty day simple moving average is $35.06 and its 200-day simple moving average is $44.99. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The firm has a market capitalization of $2.01 billion, a price-to-earnings ratio of 27.45, a price-to-earnings-growth ratio of 1.44 and a beta of 1.20. Astrana Health has a 1-year low of $29.08 and a 1-year high of $63.20.

Institutional Trading of Astrana Health

Several hedge funds and other institutional investors have recently bought and sold shares of ASTH. Nisa Investment Advisors LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at approximately $35,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Astrana Health during the 4th quarter worth approximately $40,000. Quarry LP increased its position in Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares in the last quarter. KBC Group NV acquired a new position in Astrana Health during the 3rd quarter worth approximately $70,000. Finally, Quest Partners LLC acquired a new position in Astrana Health during the 3rd quarter worth approximately $133,000. Institutional investors and hedge funds own 52.77% of the company's stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.